MLYSMineralys Therapeutics, Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$31M

Net Income

-$30M

EPS (Diluted)

$-5.77

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$455,000

Balance Sheet

Total Assets

$114M

Total Liabilities

$167M

Stockholders' Equity

-$52M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$31M	-$19M	-68.1%
Net Income	-$30M	-$19M	-53.5%

MLYS FY 2022 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena